| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |